NovaDigm Therapeutics
ID: 5290858A company focused on the development of immunotherapeutics and preventative vaccines for fungal and bacterial disease
1
Funding Rounds
$14.0m
Money raised
Recent Funding Rounds
Overview
A company focused on the development of immunotherapeutics and preventative vaccines for fungal and bacterial disease
- Website:
- Business model: B2C B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Br** Sp******* | - | - | - |
| Sc*** G. Fi**** | - | - | - |
| Yu* Fu | - | - | - |
| As**** S. Ib***** | - | - | - |
| Mi***** R. Ye**** | - | - | - |
| Jo** E. �******** Ed***** | - | - | - |
Funding series
Funding Series Analysis
The company NovaDigm Therapeutics has raised a total of $14m in funding over 1 rounds.
Key Insights:
- NovaDigm Therapeutics Series B round: $14m
Industries
NovaDigm Therapeutics is active in the following industries: